News

In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

Hero News

01/05/2022

Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer

By Tiffany Druley

Syapse said on Tuesday that it has partnered with Illumina to assess uptake and…

Read

01/05/2022

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

By Tiffany Druley

Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.

Read

01/04/2022

Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer

By Tiffany Druley

Syapse said on Tuesday that it has partnered with Illumina to assess uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.

Read

Load more

Press Releases

02/24/2022

Syapse Partners with Infor to Revolutionize Cancer Care

By Chris Burkhardt

Infor, the industry cloud company, today announced the success that Syapse has seen with cloud-based Infor CloudSuite Cloverleaf, built on Amazon Web Services® (AWS), to more easily refine and extract essential information from disparate data sources, prioritize scalability and boost privacy and security.

Read

01/20/2022

Syapse Extends Collaboration with Pfizer to Continue to Generate Real-World Evidence in Breast Cancer

By Antoinette Cummins

This is the third phase of the collaboration, which was first announced in 2019 and renewed in 2021. Additionally, Syapse will maintain clinical abstractions resources to continue to grow the breast cancer data cohort, expand research questions that can be answered, and provide Pfizer with in-depth, aggregated insights.

Read

12/16/2021

Syapse Recognized by Comparably Awards Across Four Categories

By Chris Burkhardt

Syapse® today announced that it has been recognized by its employees, via the Q4 2021 Comparably Awards, in the categories of Best Company Culture, Best CEO, Best Company for Women, and Best Company for Diversity.

Read

Load more

Events

Webinar

The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care

March 10, 2022

Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.